BNTX BioNTech SE
BNTX BioNTech SE
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $91.57 · VWAP $97.82 · -10.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
3 watchlists
BNTX Price Structure
Loading timeframes…
Peers
Every watchlist BNTX belongs to, members best 30-day change first — BNTX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
@insider-universe
Against street estimates
How BNTX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about BNTX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 25 days ago · Sep 22
- BioNTech launches USD 1.0B ADS share buyback | BNTX SEC Filing - Form 6-K
- BioNTech Announces Second Quarter 2026 Financial Results and ...
- BioNTech (BNTX) Investor Relations, Earnings Summary & Outlook
- BNTX Q2 2026 Earnings Report on 8/4/2026 - MarketBeat
- BioNTech (BNTX) Earnings Date & Report - Investing.com
BNTX research tape
88 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.